Pyc Therapeutics Ltd has released a press release.
Genentech extends research collaboration period
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- NHMRC Grant Awarded to Collaborators
- AGM Presentation to Shareholders
- Shareholder Update
- Operational Update
- Chief Executive Officer Resignation
Later from PYC Therapeutics
- Response to ASX Price Query
- Operational Update March Quarter
- CEO and CSO Appointments
- Operational Update June quarter
- Response to ASX Query
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics